The therapeutic efficacy of Xuan-Fei Bai-Du decoction in the treatment of novel coronavirus pneumonia (COVID-19): a pilot randomized controlled trial

Phase 1

Completed

• Conditions: ovel Coronavirus Pneumonia (COVID-19)

• Registration Number: ITMCTR2000003500
• Lead Sponsor: Wuhan Hospital of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Inpatients in Wuhan Pulmonary Hospital (from January 30 to February 10, 2020) who meet the diagnostic criteria of COVID-19;
2. Aged 18-75 years old;
3. According to the fourth edition of guideline, meeting the mild and severe standards;
4. Agreeing to participate in the trial;
5. No antibiotics were used during one cycle of this treatment.

Exclusion Criteria

1. According to the fourth edition of guideline, meeting the critical standard;
2. Acute respiratory diseases not caused by 2019-nCoV;
3. Asthma patients who need daily treatment;
4. Severe lung interstitial lesions, bronchiectasis and other basic lung disease patients;
5. Accompanied by severe primary immunodeficiency disease, acquired immunodeficiency syndrome, congenital respiratory malformations, congenital heart disease, abnormal lung development and other basic diseases;
6. pregnant women.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
laboratory indicators;disappearance rate of major symptoms;

Secondary Outcome Measures

Name	Time	Method
disappearance rate of other symptoms;